Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F Schellhammer

Showing results (211-220 of 215) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 215 results.
European Urology|April 15, 2000
The prognostic significance of S-phase analysis in stage Ta/T1 bladder cancer. A Southwest Oncology Group StudyR W deVere White, A D Deitch, S Daneshmand, et al.
European Urology|January 1, 1997
Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysisG S Gerber, R A Thisted, G W Chodak, et al.
Urology|January 1, 1997
Determination of the "reflex range" and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM systemA R Vashi, K J Wojno, W Henricks, et al.
The Journal of Urology|December 22, 1999
Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety studyC G Roehrborn, J McConnell, J Bonilla, et al.
Urology|September 25, 1997
Improved detection of recurrent bladder cancer using the Bard BTA stat TestM F Sarosdy, M A Hudson, W J Ellis, et al.
Pageof 22

Showing results (211-220 of 215) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 215 results.
European Urology|April 15, 2000
The prognostic significance of S-phase analysis in stage Ta/T1 bladder cancer. A Southwest Oncology Group StudyR W deVere White, A D Deitch, S Daneshmand, et al.
European Urology|January 1, 1997
Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysisG S Gerber, R A Thisted, G W Chodak, et al.
Urology|January 1, 1997
Determination of the "reflex range" and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM systemA R Vashi, K J Wojno, W Henricks, et al.
The Journal of Urology|December 22, 1999
Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety studyC G Roehrborn, J McConnell, J Bonilla, et al.
Urology|September 25, 1997
Improved detection of recurrent bladder cancer using the Bard BTA stat TestM F Sarosdy, M A Hudson, W J Ellis, et al.
Pageof 22